ReviewCurrent protocols2026
Current Overview and Main Challenges of the Use of Galleria mellonella in Biomedical Research.
Review in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Current Overview and Main Challenges of the Use of Galleria mellonella in Biomedical Research.Current protocols · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Larvae of the greater wax moth Galleria mellonella have become an increasingly important in vivo model for biomedical research, providing a practical, ethical, and biologically relevant alternative to vertebrate organisms. Its suitability as a model system lies in its low maintenance cost, ease of handling, and ability to survive at both ambient and mammalian body temperatures. Most importantly, G. mellonella exhibits an innate immune system with functional and structural parallels to that of mammals, allowing meaningful insights into infection dynamics and immune responses. This review summarizes the biological and immunological foundations that underpin the use of G. mellonella in experimental research and examines its expanding range of applications. The model has been successfully employed to study microbial pathogenicity, antimicrobial efficacy, host-pathogen interactions, and toxicological responses. In recent years, its use has extended to emerging fields such as nanomedicine, immunomodulation, and environmental biotechnology, reflecting its growing translational value. The adoption of G. mellonella also aligns with current ethical principles in science, particularly the 3Rs framework (replacement, refinement, and reduction), by minimizing the use of vertebrate animals while maintaining robust experimental outcomes. However, certain challenges persist, including the lack of adaptive immunity and the need for methodological standardization to enhance data reproducibility and comparability across laboratories. Collectively, the growing body of evidence supports G. mellonella as a reliable and versatile experimental model that bridges the gap between invertebrate and mammalian systems. Continued methodological refinement and integration with molecular and omics approaches are expected to further consolidate its role in translational and preclinical research. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.